High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations

Weberpals, 2008, Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway, J Clin Oncol, 26, 3259, 10.1200/JCO.2007.11.3902 Prat, 2005, Hereditary ovarian cancer, Hum Pathol, 36, 861, 10.1016/j.humpath.2005.06.006 Ramus, 2009, The contribution of BRCA1 and BRCA2 to ovarian cancer, Mol Oncol, 3, 138, 10.1016/j.molonc.2009.02.001 Walsh, 2008, Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas, Clin Cancer Res, 14, 7645, 10.1158/1078-0432.CCR-08-1291 Lakhani, 2004, Pathology of ovarian cancers in BRCA1 and BRCA2 carriers, Clin Cancer Res, 10, 2473, 10.1158/1078-0432.CCR-1029-3 Werness, 2000, Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations, Hum Pathol, 31, 1420, 10.1016/S0046-8177(00)80014-3 Wang, 2004, Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene, J Pathol, 202, 215, 10.1002/path.1507 Wilson, 1999, Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas, Nat Genet, 21, 236, 10.1038/6029 Zheng, 2000, Reduction of BRCA1 expression in sporadic ovarian cancer, Gynecol Oncol, 76, 294, 10.1006/gyno.1999.5664 Thrall, 2006, BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study, Int J Gynecol Cancer, 16, 166, 10.1111/j.1525-1438.2006.00504.x Brozek, 2009, Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers, J Appl Genet, 50, 379, 10.1007/BF03195697 Clark-Knowles, 2007, Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes, Exp Cell Res, 313, 133, 10.1016/j.yexcr.2006.09.026 Aghmesheh, 2004, No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers, Gynecol Oncol, 95, 430, 10.1016/j.ygyno.2004.08.035 Buller, 2001, The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer, Clin Cancer Res, 7, 831 Rhei, 1998, Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers, Cancer Res, 58, 3193 Tong, 2000, Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors, Int J Cancer, 88, 319, 10.1002/1097-0215(20001015)88:2<319::AID-IJC27>3.0.CO;2-X Villeneuve, 1999, Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer, Genes Chromosomes Cancer, 25, 65, 10.1002/(SICI)1098-2264(199905)25:1<65::AID-GCC10>3.0.CO;2-F Tavassoli, 2003 Barber, 1975, Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer, Am J Obstet Gynecol, 121, 795 Creasman, 1989, Announcement, FIGO stages 1988, revisions, Gynecol Oncol, 35, 125 Dansonka-Mieszkowska, 2006, Geographical variations in TP53 mutational spectrum in ovarian carcinomas, Ann Hum Genet, 70, 594, 10.1111/j.1469-1809.2006.00257.x Kolasa, 2009, PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients, Cancer Biol Ther, 8, 21, 10.4161/cbt.8.1.7209 Kolasa, 2006, PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations, Gynecol Oncol, 103, 692, 10.1016/j.ygyno.2006.05.007 Esteller, 2000, Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors, J Natl Cancer Inst, 92, 564, 10.1093/jnci/92.7.564 Eads, 2001, Epigenetic patterns in the progression of esophageal adenocarcinoma, Cancer Res, 61, 3410 Press, 2008, Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities, BMC Cancer, 8, 17, 10.1186/1471-2407-8-17 Majdak, 2005, Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma, Cancer, 104, 1004, 10.1002/cncr.21276 Menkiszak, 2003, Hereditary ovarian cancer in Poland, Int J Cancer, 106, 942, 10.1002/ijc.11338 Gorski, 2000, Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer, Am J Hum Genet, 66, 1963, 10.1086/302922 Janiszewska, 2003, Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland, Clin Genet, 64, 502, 10.1046/j.1399-0004.2003.00178.x Bowtell, 2010, The genesis and evolution of high-grade serous ovarian cancer, Nat Rev Cancer, 10, 803, 10.1038/nrc2946 Shih, 2004, Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis, Am J Pathol, 164, 1511, 10.1016/S0002-9440(10)63708-X Russell, 2000, Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers, Int J Cancer, 87, 317, 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B Geisler, 2002, Frequency of BRCA1 dysfunction in ovarian cancer, J Natl Cancer Inst, 94, 61, 10.1093/jnci/94.1.61 Jeng, 2007, Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation, Oncogene, 26, 6160, 10.1038/sj.onc.1210451 Werness, 2000, Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53, J Natl Cancer Inst, 92, 1088, 10.1093/jnci/92.13.1088 Baldwin, 2000, BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study, Cancer Res, 60, 5329 Ramus, 1999, Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours, Genes Chromosomes Cancer, 25, 91, 10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5 Zweemer, 1999, Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations, J Clin Pathol, 52, 372, 10.1136/jcp.52.5.372 Jazaeri, 2002, Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers, J Natl Cancer Inst, 94, 990, 10.1093/jnci/94.13.990 Ramus, 2003, BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases, Cancer Res, 63, 417